2026-06-14T03:33:15Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/149392025-04-10T11:46:46Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19608col_20.500.12105_16971
00925njm 22002777a 4500
dc
Cortes-Serra, Nuria
author
Mendes, Maria Tays
author
Mazagatos, Clara
author
Segui-Barber, Joan
author
Ellis, Cameron C
author
Ballart, Cristina
author
García-Álvarez, Ana
author
Gállego, Montserrat
author
Gascón, Joaquim
author
Almeida, Igor C
author
Pinazo, María Jesús
author
Fernandez-Becerra, Carmen
author
2020-08
Chagas disease is emerging in countries to which it is not endemic. Biomarkers for earlier therapeutic response assessment in patients with chronic Chagas disease are needed. We profiled plasma-derived extracellular vesicles from a heart transplant patient with chronic Chagas disease and showed the potential of this approach for discovering such biomarkers.
Emerg Infect Dis. 2020 Aug;26(8):1846-1851.
10.3201/eid2608.191042
1080-6059
Emerging Infectious Diseases
32687028
http://hdl.handle.net/20.500.12105/14939
Bolivia
Chagas disease
Plasma
Spain
Trypanosoma cruzi
Biomarkers
Extracellular vesicles
Heart transplantation
Parasites
Proteomic analysis
Tropical diseases
Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease